2004
DOI: 10.1111/j.1542-474x.2004.91546.x
|View full text |Cite
|
Sign up to set email alerts
|

Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods

Abstract: Background: Careful assessment of QT interval prolongation is required before novel drugs are approved by regulatory authorities. The choice of the most appropriate method of electrocardiogram (ECG) acquisition and QT/RR interval measurement in clinical trials requires better understanding of the differences among currently available approaches. This study compared standard and Holterderived 12-lead ECGs for utility in detecting sotalol-induced QT/QTc and RR changes. Manual methods (digitizing pad and digital … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
86
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 82 publications
(89 citation statements)
references
References 22 publications
3
86
0
Order By: Relevance
“…Although there is a circadian pattern of QTc intervals during the daytime hours (e.g., due to postprandial changes), the variability of QTc values when accurately measured and corrected is much smaller than previously reported (13,24,27).…”
Section: Discussionmentioning
confidence: 61%
“…Although there is a circadian pattern of QTc intervals during the daytime hours (e.g., due to postprandial changes), the variability of QTc values when accurately measured and corrected is much smaller than previously reported (13,24,27).…”
Section: Discussionmentioning
confidence: 61%
“…Healthy young adult subjects were enrolled in a previously reported study [5] exploring electrocardiographic identification of drug-induced QT prolongation following treatment with rac-sotalol. The study was open-label, non-randomized with a fixed treatment sequence on 3 consecutive days: a separate baseline day (day 0), a single oral 160 mg dose of rac-sotalol (Betapace®,Berlex Laboratories) on day 1 and a single 320 mg dose of rac-sotalol on day 2.…”
Section: Study Outlinementioning
confidence: 99%
“…Premenopausal women have on average a 10 to 20 ms longer QTc interval than men [3][4][5] and it is well described that women are at higher risk for the development of pro-arrhythmias caused by drugs with an effect on cardiac repolarization, i.e. drugs that further prolong the QTc interval [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…snapshots of the definitive 12-lead ECGs provide an insight into continuous assessment of arrhythmias (Sarapa et al, 2004).…”
Section: Drug Trials and Safety (Qt And Arrhythmia Evaluation)mentioning
confidence: 99%